Publication | Open Access

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy

UrologyCancer ImmunosurveillanceGenitourinary CancerMedicineImmunologyTumor ImmunityImmune Checkpoint InhibitorNeutrophil-to-lymphocyte RatioTargeted TherapyOncologyTumor Microenvironment